🇮🇳 ABROCITINIB in India

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ABROCITINIB (ABROCITINIB) regulatory status in India.

Marketing authorisation

CDSCO

Status: likely_approved

ABROCITINIB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ABROCITINIB approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for ABROCITINIB in India?

Marketing authorisation holder not available in our data.